Your browser doesn't support javascript.
loading
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH).
Meric-Bernstam, Funda; Ford, James M; O'Dwyer, Peter J; Shapiro, Geoffrey I; McShane, Lisa M; Freidlin, Boris; O'Cearbhaill, Roisin E; George, Suzanne; Glade-Bender, Julia; Lyman, Gary H; Tricoli, James V; Patton, David; Hamilton, Stanley R; Gray, Robert J; Hawkins, Douglas S; Ramineni, Bhanumati; Flaherty, Keith T; Grivas, Petros; Yap, Timothy A; Berlin, Jordan; Doroshow, James H; Harris, Lyndsay N; Moscow, Jeffrey A.
Afiliación
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ford JM; Department of Medicine - Oncology, Stanford University, Stanford, California.
  • O'Dwyer PJ; Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McShane LM; Biometric Research Program, DCTD, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Freidlin B; Biometric Research Program, DCTD, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • O'Cearbhaill RE; Department of Medicine, Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College, New York, New York.
  • George S; Sarcoma and Bone Oncology Division, Medical Oncology Department, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Glade-Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lyman GH; Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington.
  • Tricoli JV; Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland.
  • Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hamilton SR; Department of Pathology, City of Hope National Medical Center, Duarte, California.
  • Gray RJ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hawkins DS; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.
  • Ramineni B; Cancer Therapy Evaluation Program, Regulatory Affairs Branch, DCTD, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Flaherty KT; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Grivas P; Department of Medicine, Division of Medical Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington.
  • Yap TA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Berlin J; Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Moscow JA; Investigational Drug Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Clin Cancer Res ; 29(8): 1412-1422, 2023 04 14.
Article en En | MEDLINE | ID: mdl-36662819
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article